Riester A.I CyberSecurity Scoring
26/12/2025
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Riester in 2026.
No incidents recorded for Riester in 2026.
No incidents recorded for Riester in 2026.
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
As a leading medical technology company, B. Braun protects and improves the health of people around the world. For more than 185 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits. More than 64,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops integrated solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2024, the B. Braun Group generated sales of € 9.1 billion. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Latest updates, reports, and threat intel affecting the global network.
Usually 'first in, last out' XCOMM airmen are called on to establish communications in a different environment.
mem0's openmemory/api component contains an unauthenticated access vulnerability that allows unauthenticated attackers to read, write, and delete arbitrary user memories by accessing API routers registered without authentication middleware. Attackers can supply arbitrary user_id parameters or directly access memory retrieval endpoints to expose private memory content, or invoke pause endpoints with global_pause=true to cause denial-of-service across all users.
Cap's GET /api/video/ai endpoint fails to validate user ownership or membership before returning private video AI metadata including titles, summaries, and chapters. Authenticated attackers can supply arbitrary video IDs to read sensitive AI-generated content and trigger unauthorized AI generation that consumes the video owner's credits without consent.
Coder allows organizations to provision remote development environments via Terraform. Starting in version 2.17.0 and prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, `POST /api/v2/files` converts zip uploads to tar in memory via `CreateTarFromZip`, which enforced a per-entry size limit but no aggregate limit on total decompressed output, writing to an unbounded in-memory buffer. Exploitation requires authenticated file-upload access and the impact is limited to availability (denial of service). The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 adds a metadata preflight check that sums projected entry sizes and a streaming writer that enforces the aggregate limit during decompression. As a workaround, restrict file-upload permissions to trusted users or place a reverse proxy with request-body size limits in front of `coderd`.
Coder allows organizations to provision remote development environments via Terraform. Prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, the `PUT /api/v2/users/{user}/password` endpoint authorized only `ActionUpdatePersonal` and did not prevent a `user-admin` from resetting an `owner` account's password. It also did not require the current password when an admin reset another user's password. Exploitation requires the privileged `user-admin` role so practical risk is limited to deployments that grant `user-admin` to less trusted operators. The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 prevents non-owner users from resetting the password of an account that holds the `owner` role. As a workaround, restrict the `user-admin` role to trusted administrators.
Coder allows organizations to provision remote development environments via Terraform. Prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, Coder's OIDC callback checked `email_verified` with a direct Go `bool` type assertion. When an IdP returned the claim as a non-boolean (for example the string `"false"`) or omitted it, the assertion failed open and the email was treated as verified. Combined with an unconditional email-based account fallback, this enabled account takeover. The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 coerces `email_verified` across bool, string and numeric types (fail-closed) and blocks the email fallback when the matched user already has a different linked IdP subject. As a workaround, ensure the IdP returns `email_verified` as a native JSON boolean. The email-fallback linking issue has no configuration workaround; upgrading is required.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.